Latest Development, Product Innovations and Treatments for Diabetes
REPORT SCOPE:
The key objectives of this study are to -
Review the impact that diabetes is having on global health. This includes -
REPORT INCLUDES:
The key objectives of this study are to -
Review the impact that diabetes is having on global health. This includes -
- Review of diabetes as a disease.
- Review of the epidemiology of diabetes.
- Data and statistics by region.
- Predictions of future incidence and prevalence of diabetes globally and by region.
- Review of the impact that diabetes has and will have in the future.
- Review of the current products available within the following individual product segment and subsegments.
- Blood glucose monitoring and diagnostic systems and devices.
- Insulin-delivery devices.
- Antidiabetic medications.
- Flash glucose monitoring (FGM).
- New and novel approaches to blood glucose monitoring.
- Review of the latest developments in continuous glucose monitoring (CGM) systems.
- Insulin syringes.
- Insulin pens and needles (reusable and disposable).
- Insulin jet injectors.
- External insulin pumps.
- Implantable insulin pumps.
- Insulin inhalers.
- Insulin patches.
- Review of the classification of Antidiabetic medications under the titles of injectable Antidiabetic medications and oral Antidiabetic drugs (OADS).
- Review of the current product pipeline for new and innovative Antidiabetic medications.
- Review the range of joint ventures, collaborations, licenses and research agreements currently focused on new medical device technologies.
- Review of the regulatory requirements, intellectual property protection and concerns, patents and trademark process.
- Review of the impact that the new and improved technologies will have on market dynamics by geographic region.
- Survey of the key players involved in the development of new and innovative medical device technologies and Antidiabetic medications together with major improvements to existing technologies, as well as company profiles.
- An improved understanding of the current state, future developments and latest product innovations in both medical devices and medications used to treat diabetes.
- The latest information on the leading companies engaged in developing new and improving existing medical devices and medications, a review of the status of their product pipelines and insight into their proprietary technologies.
- An understanding of the impact that these new products and technologies will have on the growth and development of the medical market.
- An appreciation of how these new medical devices and medications will affect the provision of healthcare, how they will provide clinicians with new methods to treat existing conditions and how these technologies will improve clinical outcomes for patients.
- An appreciation of the market restraints and drivers influencing the growth and development of this market.
- The impact that diabetes has on the population and the implications as a global pandemic.
REPORT INCLUDES:
- 72 data tables and 33 additional tables
- An overview of global market for diabetes treatment and discussion on latest developments and product innovations in the industry
- Analyses of global market trends, with data from 2018, 2019, and projections of compound annual growth rates (CAGRs) through 2024
- Coverage of diabetes background, its prevalence and its threat to world health
- Briefing about blood glucose monitoring and diagnostic systems and devices
- Discussion on top drug treatments and their latest breakthroughs
- Information on the artificial, or “Bionic” pancreas
- A look at the measures taken to confront diabetes at the local, regional, national and trans-national level by raising awareness in parliaments and assemblies across the world
- Evaluation of current market size, market forecast, and market share analysis of the leading suppliers of the industry
- Insights into individual country policies and strategies to combat diabetes
- Comprehensive company profiles of key players in the market, including Abbott Laboratories, Becton, Dickinson and Co., Eli Lilly and Co., GlaxoSmithKline PLC and NextCell Pharma AB
CHAPTER 1 INTRODUCTION
Introduction
Diabetes
Type 1 Diabetes
Type 2 Diabetes
Scope of Report
Methodology and Information Sources
Primary Data and Information Gathering
Secondary Data and Information Gathering
Market Revenue Forecasts
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
CHAPTER 2 SUMMARY AND HIGHLIGHTS
Global Market for Diabetes Treatments
Regional Overview
Market Segmentation
Major Developments and Trends in Innovative Diabetes Treatment Technologies
Blood Glucose Monitoring and Diagnostic Systems and Devices
Insulin Delivery Devices
Diabetic Medications
CHAPTER 3 INTRODUCTION TO DIABETES AND ITS THREAT TO WORLD HEALTH
Introduction to Diabetes
What is Diabetes?
Types of Diabetes
Type 1 Diabetes
Type 2 Diabetes
Gestational Diabetes Mellitus (GDM) or Hyperglycemia in Pregnancy
Impaired Glucose Tolerance (IGT) and Impaired Fasting Glucose (IFG)
Epidemiology of Diabetes
Gender Distribution
Regional Disparities
Data and Statistics by Region
Key Facts and Latest Data: North America and the Caribbean Region
Key Facts and Latest Data: Europe
Key Facts and Latest Data: South and Central America
Key Facts and Latest Data: Southeast Asia
Key Facts and Latest Data: Western Pacific
Key Facts and Latest Data: Middle East and North Africa
Key Facts and Latest Data: Africa
Top 10 Countries/Territories for Number of People Aged 20-79 with Diabetes
Undiagnosed Diabetes
Healthcare Expenditure Associated with Diabetes
CHAPTER 4 BLOOD GLUCOSE MONITORING AND DIAGNOSTIC SYSTEMS AND DEVICES
Introduction to Blood Glucose Monitoring and Diagnostic Systems and Devices
Self-Monitoring of Blood Glucose (SMBG)
SMBG Market Structure
Latest Technological Advances and Developments in Blood Glucose Devices
Continuous Glucose Monitoring (CGM) Systems
History and Development of CGM Systems
CHAPTER 5 INSULIN DELIVERY DEVICES
Introduction to Insulin Delivery Devices
Insulin Syringes
Advantages of Using Insulin Syringes
Disadvantages of Using Insulin Syringes
Latest Technological Advances and Developments in Insulin Syringes
Insulin Delivery Pen Devices
Disposable Insulin Pens
Reusable Insulin Pens
Latest Technological Advances and Developments in Insulin Delivery Pen Devices
Insulin Jet Injectors
Advantages of Using Insulin Jet injectors
Disadvantages of Using Insulin Jet injectors
External Insulin Pumps
Advantages of Insulin Pumps
Disadvantages of Insulin Pumps
Latest Technological Advances and Developments in Insulin Pump Systems
Implantable Insulin Pumps
Closed-Loop Artificial Pancreas
Bionic Pancreas
The Artificial Pancreas (the Physiological Approach)
Insulin Inhalers
Advantages of Insulin Inhalers
Disadvantages of Insulin Inhalers
Types of Insulin Inhalers
Insulin Patches
Prometheon Pharma
CeQur SA
EOFlow
Zenomics Inc.
Oral Insulin Delivery
Novo Nordisk and NIH Funds Research at MIT
Oramed Pharmaceuticals
Diabetology Ltd.
CHAPTER 6 ANTIDIABETIC MEDICATIONS
Introduction
Classification and Types of Antidiabetic Medications
Injectable Therapies for Diabetes
Oral Antidiabetic Drugs (OADs)
Facing the Patent Cliff
Latest Technological Advances, Developments and Product Pipelines for Diabetic Medications
Current Product Pipeline
Other Potential Therapies Currently Under Investigation
CHAPTER 7 REGIONAL MARKETS FOR DIABETES TREATMENTS
Introduction
Global Market for Diabetes Treatments
Regional Overview
North American Market for Diabetes Treatments
European Market for Diabetes Treatments
Asia-Pacific Market for Diabetes Treatments
Latin American Market for Diabetes Treatments
Middle Eastern and African Market for Diabetes Treatments
Market Factors Driving the Growth and Development of the Diabetic Pharmaceutical Market
Market Drivers
Market Restraints
CHAPTER 8 GLOBAL MARKET FOR GLUCOSE MONITORING AND DIAGNOSTIC PRODUCTS
Introduction
Global Glucose Monitoring and Diagnostic Product Market
Overview of the Regional Markets
Glucose Monitoring and Diagnostic Product Market by Region
North America
Europe
Asia-Pacific
Latin America
Middle East and Africa
Global Market Share Analysis
Glucose Monitoring and Diagnostic Products
Blood Glucose Test Strips, Glucose Meters, Lancets and Lancet Devices
Continuous Glucose Monitoring Products
CHAPTER 9 GLOBAL MARKET FOR INSULIN DELIVERY PRODUCTS AND DEVICES
Introduction
Global Insulin Delivery Products and Devices Market
Overview of the Regional Markets
Insulin Delivery Products and Device Market by Region
North America
Europe
Asia-Pacific
Latin America
Middle East and Africa
Market Share Analysis
CHAPTER 10 GLOBAL MARKET FOR ANTIDIABETIC PHARMACEUTICALS
Introduction
Global Antidiabetic Pharmaceutical Market
Overview of the Regional Markets
Antidiabetic Pharmaceuticals Market by Region
North America
Europe
Asia-Pacific
Latin America
Middle East and Africa
Market Share Analysis
CHAPTER 11 COMPANY PROFILES
Introduction
Tier 1 Major Multinational Medical Device Corporations
ABBOTT LABORATORIES
ASCENSIA DIABETES CARE HOLDINGS AG
ASTRAZENECA PLC
BAYER AG
BECTON, DICKINSON AND CO.
BECKMAN COULTER (PART OF DANAHER)
BOSTON SCIENTIFIC CORP.
B. BRAUN MELSUNGEN AG
ELI LILLY AND CO.
GLAXOSMITHKLINE PLC
INSULET CORP.
JOHNSON & JOHNSON
LIFESCAN INC.
MEDTRONIC INC.
NOVO NORDISK A/S
PFIZER INC.
ROCHE (FORMERLY HOFFMANN-LA ROCHE LTD.)
SANOFI S.A.
TERUMO CORP.
Tier 2 Entrepreneurial Small and Medium-Sized Enterprises
AGAMATRIX INC.
ALTUCELL INC.
BETA-O2 TECHNOLOGIES
BETALIN THERAPEUTICS
DARIOHEALTH CORP.
DEXCOM INC.
EVOTEC SE
LEXICON PHARMACEUTICALS INC.
MESOBLAST LTD.
NEXTCELL PHARMA AB
ORGENESIS INC.
OSIRIS THERAPEUTICS INC. (SUBSIDIARY OF SMITH & NEPHEW PLC)
SENSEONICS HOLDINGS INC.
SERNOVA CORP.
SERAXIS INC.
TANDEM DIABETES CARE, INC.
VALERITAS HOLDINGS INC.
VIACYTE INC.
VTV THERAPEUTICS INC.
UNICYTE AG
YPSOMED HOLDING AG
CHAPTER 12 APPENDIX: A
Company Contact Information
Tier 1 Major Multinational Medical Device Corporations
CHAPTER 13 APPENDIX: B
Company Contact Information
Tier 2 Entrepreneurial Small and Medium-Sized Enterprises (SMEs)
CHAPTER 14 APPENDIX: C
Government Regulatory Agencies and Professional Organizations
CHAPTER 15 APPENDIX: D
Acronyms and Terms Commonly Used in the Diagnosis, Monitoring and Treatment of Diabetes
Introduction
Diabetes
Type 1 Diabetes
Type 2 Diabetes
Scope of Report
Methodology and Information Sources
Primary Data and Information Gathering
Secondary Data and Information Gathering
Market Revenue Forecasts
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
CHAPTER 2 SUMMARY AND HIGHLIGHTS
Global Market for Diabetes Treatments
Regional Overview
Market Segmentation
Major Developments and Trends in Innovative Diabetes Treatment Technologies
Blood Glucose Monitoring and Diagnostic Systems and Devices
Insulin Delivery Devices
Diabetic Medications
CHAPTER 3 INTRODUCTION TO DIABETES AND ITS THREAT TO WORLD HEALTH
Introduction to Diabetes
What is Diabetes?
Types of Diabetes
Type 1 Diabetes
Type 2 Diabetes
Gestational Diabetes Mellitus (GDM) or Hyperglycemia in Pregnancy
Impaired Glucose Tolerance (IGT) and Impaired Fasting Glucose (IFG)
Epidemiology of Diabetes
Gender Distribution
Regional Disparities
Data and Statistics by Region
Key Facts and Latest Data: North America and the Caribbean Region
Key Facts and Latest Data: Europe
Key Facts and Latest Data: South and Central America
Key Facts and Latest Data: Southeast Asia
Key Facts and Latest Data: Western Pacific
Key Facts and Latest Data: Middle East and North Africa
Key Facts and Latest Data: Africa
Top 10 Countries/Territories for Number of People Aged 20-79 with Diabetes
Undiagnosed Diabetes
Healthcare Expenditure Associated with Diabetes
CHAPTER 4 BLOOD GLUCOSE MONITORING AND DIAGNOSTIC SYSTEMS AND DEVICES
Introduction to Blood Glucose Monitoring and Diagnostic Systems and Devices
Self-Monitoring of Blood Glucose (SMBG)
SMBG Market Structure
Latest Technological Advances and Developments in Blood Glucose Devices
Continuous Glucose Monitoring (CGM) Systems
History and Development of CGM Systems
CHAPTER 5 INSULIN DELIVERY DEVICES
Introduction to Insulin Delivery Devices
Insulin Syringes
Advantages of Using Insulin Syringes
Disadvantages of Using Insulin Syringes
Latest Technological Advances and Developments in Insulin Syringes
Insulin Delivery Pen Devices
Disposable Insulin Pens
Reusable Insulin Pens
Latest Technological Advances and Developments in Insulin Delivery Pen Devices
Insulin Jet Injectors
Advantages of Using Insulin Jet injectors
Disadvantages of Using Insulin Jet injectors
External Insulin Pumps
Advantages of Insulin Pumps
Disadvantages of Insulin Pumps
Latest Technological Advances and Developments in Insulin Pump Systems
Implantable Insulin Pumps
Closed-Loop Artificial Pancreas
Bionic Pancreas
The Artificial Pancreas (the Physiological Approach)
Insulin Inhalers
Advantages of Insulin Inhalers
Disadvantages of Insulin Inhalers
Types of Insulin Inhalers
Insulin Patches
Prometheon Pharma
CeQur SA
EOFlow
Zenomics Inc.
Oral Insulin Delivery
Novo Nordisk and NIH Funds Research at MIT
Oramed Pharmaceuticals
Diabetology Ltd.
CHAPTER 6 ANTIDIABETIC MEDICATIONS
Introduction
Classification and Types of Antidiabetic Medications
Injectable Therapies for Diabetes
Oral Antidiabetic Drugs (OADs)
Facing the Patent Cliff
Latest Technological Advances, Developments and Product Pipelines for Diabetic Medications
Current Product Pipeline
Other Potential Therapies Currently Under Investigation
CHAPTER 7 REGIONAL MARKETS FOR DIABETES TREATMENTS
Introduction
Global Market for Diabetes Treatments
Regional Overview
North American Market for Diabetes Treatments
European Market for Diabetes Treatments
Asia-Pacific Market for Diabetes Treatments
Latin American Market for Diabetes Treatments
Middle Eastern and African Market for Diabetes Treatments
Market Factors Driving the Growth and Development of the Diabetic Pharmaceutical Market
Market Drivers
Market Restraints
CHAPTER 8 GLOBAL MARKET FOR GLUCOSE MONITORING AND DIAGNOSTIC PRODUCTS
Introduction
Global Glucose Monitoring and Diagnostic Product Market
Overview of the Regional Markets
Glucose Monitoring and Diagnostic Product Market by Region
North America
Europe
Asia-Pacific
Latin America
Middle East and Africa
Global Market Share Analysis
Glucose Monitoring and Diagnostic Products
Blood Glucose Test Strips, Glucose Meters, Lancets and Lancet Devices
Continuous Glucose Monitoring Products
CHAPTER 9 GLOBAL MARKET FOR INSULIN DELIVERY PRODUCTS AND DEVICES
Introduction
Global Insulin Delivery Products and Devices Market
Overview of the Regional Markets
Insulin Delivery Products and Device Market by Region
North America
Europe
Asia-Pacific
Latin America
Middle East and Africa
Market Share Analysis
CHAPTER 10 GLOBAL MARKET FOR ANTIDIABETIC PHARMACEUTICALS
Introduction
Global Antidiabetic Pharmaceutical Market
Overview of the Regional Markets
Antidiabetic Pharmaceuticals Market by Region
North America
Europe
Asia-Pacific
Latin America
Middle East and Africa
Market Share Analysis
CHAPTER 11 COMPANY PROFILES
Introduction
Tier 1 Major Multinational Medical Device Corporations
ABBOTT LABORATORIES
ASCENSIA DIABETES CARE HOLDINGS AG
ASTRAZENECA PLC
BAYER AG
BECTON, DICKINSON AND CO.
BECKMAN COULTER (PART OF DANAHER)
BOSTON SCIENTIFIC CORP.
B. BRAUN MELSUNGEN AG
ELI LILLY AND CO.
GLAXOSMITHKLINE PLC
INSULET CORP.
JOHNSON & JOHNSON
LIFESCAN INC.
MEDTRONIC INC.
NOVO NORDISK A/S
PFIZER INC.
ROCHE (FORMERLY HOFFMANN-LA ROCHE LTD.)
SANOFI S.A.
TERUMO CORP.
Tier 2 Entrepreneurial Small and Medium-Sized Enterprises
AGAMATRIX INC.
ALTUCELL INC.
BETA-O2 TECHNOLOGIES
BETALIN THERAPEUTICS
DARIOHEALTH CORP.
DEXCOM INC.
EVOTEC SE
LEXICON PHARMACEUTICALS INC.
MESOBLAST LTD.
NEXTCELL PHARMA AB
ORGENESIS INC.
OSIRIS THERAPEUTICS INC. (SUBSIDIARY OF SMITH & NEPHEW PLC)
SENSEONICS HOLDINGS INC.
SERNOVA CORP.
SERAXIS INC.
TANDEM DIABETES CARE, INC.
VALERITAS HOLDINGS INC.
VIACYTE INC.
VTV THERAPEUTICS INC.
UNICYTE AG
YPSOMED HOLDING AG
CHAPTER 12 APPENDIX: A
Company Contact Information
Tier 1 Major Multinational Medical Device Corporations
CHAPTER 13 APPENDIX: B
Company Contact Information
Tier 2 Entrepreneurial Small and Medium-Sized Enterprises (SMEs)
CHAPTER 14 APPENDIX: C
Government Regulatory Agencies and Professional Organizations
CHAPTER 15 APPENDIX: D
Acronyms and Terms Commonly Used in the Diagnosis, Monitoring and Treatment of Diabetes
LIST OF TABLES
Summary Table A: Global Market for Diabetes Treatment, Through 2024
Summary Table B: Global Market for Diabetes Treatment, by Region, Through 2024
Summary Table C: Global Market Shares of Diabetes Treatment, by Region, 2019
Summary Table D: Global Market for Diabetes Treatment, by Product Segment/Subsegment, Through 2024
Table 1: Key Facts and Latest Data for Diabetes Globally, 2017 and 2045
Table 2: IDF Regions Ranked by Prevalence of Diabetes Population Aged 20-79 Years per Region, 2017 and 2045
Table 3: Key Facts and Latest Data for Diabetes Across the North American and Caribbean Regions, 2017 and 2045
Table 4: Key Facts and Latest Data for Diabetes in Europe, 2017 and 2045
Table 5: Key Facts and Latest Data for Diabetes in South and Central America, 2017 and 2045
Table 6: Key Facts and Latest Data for Diabetes in Southeast Asia, 2017 and 2045
Table 7: Key Facts and Latest Data for Diabetes in Western Pacific, 2017 and 2045
Table 8: Key Facts and Latest Data for Diabetes in the Middle East and North Africa, 2017 and 2045
Table 9: Key Facts and Latest Data for Diabetes in Africa, 2017 and 2045
Table 10: Top 10 Countries/Territories with People Aged 20-79 Years Living with Diabetes, 2017 and 2045
Table 11: People Aged 20-79 Years Living with Undiagnosed Diabetes by Region, 2017
Table 12: Top 10 Countries with People Aged 20-79 Years Living with Undiagnosed Diabetes, 2017
Table 13: Ranking of Top 10 Countries Based on Total Healthcare Expenditures on People Aged 20-79 Years with Diabetes, 2017
Table 14: Leading Blood Glucose Manufacturers and Blood Glucose Products
Table 15: Leading Lancet and Lancet Device Manufacturers and Products
Table 16: Comparison of Abbott Freestyle Blood Glucose Monitoring System Readers
Table 17: Leading Insulin Syringes Manufacturers and Insulin Syringe Products
Table 18: Commercially Available Insulin Injector Pens
Table 19: Leading Insulin Jet Injectors Manufacturers and Products
Table 20: Leading External Insulin Pump Manufacturers and Products
Table 21: Key Features of Current Leading Insulin Pump Systems
Table 22: Comparison of Insulin Action of Leading Insulin Products
Table 23: Comparison of GLP-1 Analogs
Table 24: U.S. Patent Expiry Dates for the World's Top Selling Diabetes Drugs
Table 25: Novo Nordisk's Current R&D Pipeline
Table 26: Eli Lilly and Co.'s Current R&D Pipeline
Table 27: AstraZeneca's Current R&D Pipeline
Table 28: Terminology Used to Describe Generic Biopharmaceuticals, by Country/Region
Table 29: Global Market for Diabetes Treatment Technologies, Through 2024
Table 30: Global Market for Diabetes Treatment, by Product Segment/Subsegment, Through 2024
Table 31: Global Market Shares of Diabetes Treatment Technologies, by Product Segment/Subsegment, 2019
Table 32: Global Market Shares of Diabetes Treatment Technologies, by Region, 2019
Table 33: Global Market for Diabetes Treatment, by Region, Through 2024
Table 34: North American Market for Diabetes Treatment, by Product Segment, Through 2024
Table 35: European Market for Diabetes Treatment, by Product Segment, Through 2024
Table 36: Asia-Pacific Market for Diabetes Treatment, by Product Segment, Through 2024
Table 37: Latin American Market for Diabetes Treatment, by Product Segment, Through 2024
Table 38: Middle Eastern and African Market for Diabetes Treatment, by Product Segment, Through 2024
Table 39: Global Market for Glucose Monitoring and Diagnostic Products, Through 2024
Table 40: Global Market for Glucose Monitoring and Diagnostic Products, by Product Subsegment, Through 2024
Table 41: Global Market Shares of Glucose Monitoring and Diagnostic Products, by Product Subsegment, 2019
Table 42: Global Market Shares of Glucose Monitoring and Diagnostic Products, by Region, 2019
Table 43: Global Market for Glucose Monitoring and Diagnostic Products, by Region, Through 2024
Table 44: North American Market for Glucose Monitoring and Diagnostic Products, by Country, Through 2024
Table 45: European Market for Glucose Monitoring and Diagnostics Products, by Country, Through 2024
Table 46: Asia-Pacific Market for Glucose Monitoring and Diagnostic Products, by Country, Through 2024
Table 47: Latin American Market for Glucose Monitoring and Diagnostic Products, by Country, Through 2024
Table 48: Middle Eastern and African Market for Glucose Monitoring and Diagnostic Products, by Country/Region, Through 2024
Table 49: Global Company Market Shares of Glucose Monitoring and Diagnostic Products, 2019
Table 50: Global Market Shares of Blood Glucose Test Strips, Glucose Meters, Lancets and Lancet Devices, by Company, 2019
Table 51: Global Company Market Shares of Continuous Glucose Monitoring Products, 2019
Table 52: Global Market for Insulin Delivery Products and Devices, Through 2024
Table 53: Global Market for Insulin Delivery Products and Devices, by Type, Through 2024
Table 54: Global Market Shares of Insulin Delivery Products and Devices, by Type, 2019
Table 55: Global Market Shares of Insulin Delivery Products and Devices, by Region, 2019
Table 56: Global Market for Insulin Delivery Products and Devices, by Region, Through 2024
Table 57: North American Market for Insulin Delivery Products and Devices, by Country, Through 2024
Table 58: European Market for Insulin Delivery Products and Devices, by Country, Through 2024
Table 59: Asia-Pacific Market for Insulin Delivery Products and Devices, by Country, Through 2024
Table 60: Latin American Market for Insulin Delivery Products and Devices, by Country, Through 2024
Table 61: Middle Eastern and African Market for Insulin Delivery Products and Devices, by Country/Region, Through 2024
Table 62: Global Company Market Shares of Insulin Delivery Products and Devices, 2019
Table 63: Global Market for Diabetic Pharmaceuticals, Through 2024
Table 64: Global Market for Diabetic Pharmaceuticals, by Product Type, Through 2024
Table 65: Global Market Shares of Diabetic Pharmaceuticals, by Product Type, 2019
Table 66: Global Revenues of Leading Antidiabetic Pharmaceutical Companies, 2016-2018
Table 67: Global Market Shares of Diabetic Pharmaceuticals, by Region, 2019
Table 68: Global Market for Diabetic Pharmaceuticals, by Region, Through 2024
Table 69: North American Market for Antidiabetic Pharmaceuticals, by Country, Through 2024
Table 70: European Market for Antidiabetic Pharmaceuticals, by Country, Through 2024
Table 71: Major Chinese Pharmaceutical Companies Developing Antidiabetic Medicines, by Type
Table 72: Asia-Pacific Market for Antidiabetic Pharmaceuticals, by Country, Through 2024
Table 73: Latin American Market for Antidiabetic Pharmaceuticals, by Country, Through 2024
Table 74: Middle Eastern and African Market for Antidiabetic Pharmaceuticals, by Country/Region, Through 2024
Table 75: Global Market Shares of Antidiabetic Pharmaceutical Companies, 2019
Table 76: Abbott Laboratories Revenue, by Business Segment, 2016-2018
Table 77: AstraZeneca PLC Revenue, by Business Segment, 2016-2018
Table 78: AstraZeneca PLC Revenue, by Individual Product, 2018
Table 79: Becton Dickinson Revenue, by Business Segment, 2016-2018
Table 80: Danaher Corp. Revenue, by Business Segment, 2016-2018
Table 81: Boston Scientific Corp. Revenue, by Product Segment, 2016-2018
Table 82: Boston Scientific Corp. Recent Developments, August 2018-May 2019
Table 83: B. Braun Melsungen AG Revenue, by Product Segment, 2016-2018
Table 84: Eli Lilly and Co. Revenue, by Product Segment, 2016-2018
Table 85: GlaxoSmithKline PLC Revenue, by Product Segment, 2016-2018
Table 86: Insulet Corp. Revenue, by Product Segment, 2016-2018
Table 87: Johnson & Johnson Revenue, by Product Segment, 2016-2018
Table 88: Medtronic Inc. Revenue, by Product Segment, 2017-2019
Table 89: Medtronic Inc. Recent Developments, June 2014-May 2019
Table 90: Novo Nordisk A/S Revenue, by Product Segment, 2016-2018
Table 91: Novo Nordisk A/S Revenue, Diabetes and Obesity, 2016-2018
Table 92: Novo Nordisk A/S Revenue, Biopharmaceuticals, 2016-2018
Table 93: Novo Nordisk A/S: Product Development Portfolio
Table 94: Pfizer Inc. Revenue, by Product Segment, 2016-2018
Table 95: Roche Group Revenue, by Product Segment, 2016-2018
Table 96: Roche Group Revenue, by Diagnostic Segment, 2016-2018
Table 97: Roche Group: Product Development Portfolio (Diagnostics)
Table 98: Sanofi S.A. Revenue, by Product Segment, 2016-2018
Table 99: Sanofi S.A. Diabetes Revenue, by Product Segment, 2016-2018
Table 100: Terumo Corp. Revenue, by Business Division, 2016-March 31, 2018
Table 101: Contact Information for Tier 1 Major Multinational Medical Device Corporations
Table 102: Contact Information for Tier 2 Entrepreneurial Small and Medium-Sized Enterprises
Table 103: Government Regulatory Agencies and Professional Organizations
Table 104: Acronyms and Terms Commonly Used in the Diagnosis, Monitoring and Treatment of Diabetes
Summary Table A: Global Market for Diabetes Treatment, Through 2024
Summary Table B: Global Market for Diabetes Treatment, by Region, Through 2024
Summary Table C: Global Market Shares of Diabetes Treatment, by Region, 2019
Summary Table D: Global Market for Diabetes Treatment, by Product Segment/Subsegment, Through 2024
Table 1: Key Facts and Latest Data for Diabetes Globally, 2017 and 2045
Table 2: IDF Regions Ranked by Prevalence of Diabetes Population Aged 20-79 Years per Region, 2017 and 2045
Table 3: Key Facts and Latest Data for Diabetes Across the North American and Caribbean Regions, 2017 and 2045
Table 4: Key Facts and Latest Data for Diabetes in Europe, 2017 and 2045
Table 5: Key Facts and Latest Data for Diabetes in South and Central America, 2017 and 2045
Table 6: Key Facts and Latest Data for Diabetes in Southeast Asia, 2017 and 2045
Table 7: Key Facts and Latest Data for Diabetes in Western Pacific, 2017 and 2045
Table 8: Key Facts and Latest Data for Diabetes in the Middle East and North Africa, 2017 and 2045
Table 9: Key Facts and Latest Data for Diabetes in Africa, 2017 and 2045
Table 10: Top 10 Countries/Territories with People Aged 20-79 Years Living with Diabetes, 2017 and 2045
Table 11: People Aged 20-79 Years Living with Undiagnosed Diabetes by Region, 2017
Table 12: Top 10 Countries with People Aged 20-79 Years Living with Undiagnosed Diabetes, 2017
Table 13: Ranking of Top 10 Countries Based on Total Healthcare Expenditures on People Aged 20-79 Years with Diabetes, 2017
Table 14: Leading Blood Glucose Manufacturers and Blood Glucose Products
Table 15: Leading Lancet and Lancet Device Manufacturers and Products
Table 16: Comparison of Abbott Freestyle Blood Glucose Monitoring System Readers
Table 17: Leading Insulin Syringes Manufacturers and Insulin Syringe Products
Table 18: Commercially Available Insulin Injector Pens
Table 19: Leading Insulin Jet Injectors Manufacturers and Products
Table 20: Leading External Insulin Pump Manufacturers and Products
Table 21: Key Features of Current Leading Insulin Pump Systems
Table 22: Comparison of Insulin Action of Leading Insulin Products
Table 23: Comparison of GLP-1 Analogs
Table 24: U.S. Patent Expiry Dates for the World's Top Selling Diabetes Drugs
Table 25: Novo Nordisk's Current R&D Pipeline
Table 26: Eli Lilly and Co.'s Current R&D Pipeline
Table 27: AstraZeneca's Current R&D Pipeline
Table 28: Terminology Used to Describe Generic Biopharmaceuticals, by Country/Region
Table 29: Global Market for Diabetes Treatment Technologies, Through 2024
Table 30: Global Market for Diabetes Treatment, by Product Segment/Subsegment, Through 2024
Table 31: Global Market Shares of Diabetes Treatment Technologies, by Product Segment/Subsegment, 2019
Table 32: Global Market Shares of Diabetes Treatment Technologies, by Region, 2019
Table 33: Global Market for Diabetes Treatment, by Region, Through 2024
Table 34: North American Market for Diabetes Treatment, by Product Segment, Through 2024
Table 35: European Market for Diabetes Treatment, by Product Segment, Through 2024
Table 36: Asia-Pacific Market for Diabetes Treatment, by Product Segment, Through 2024
Table 37: Latin American Market for Diabetes Treatment, by Product Segment, Through 2024
Table 38: Middle Eastern and African Market for Diabetes Treatment, by Product Segment, Through 2024
Table 39: Global Market for Glucose Monitoring and Diagnostic Products, Through 2024
Table 40: Global Market for Glucose Monitoring and Diagnostic Products, by Product Subsegment, Through 2024
Table 41: Global Market Shares of Glucose Monitoring and Diagnostic Products, by Product Subsegment, 2019
Table 42: Global Market Shares of Glucose Monitoring and Diagnostic Products, by Region, 2019
Table 43: Global Market for Glucose Monitoring and Diagnostic Products, by Region, Through 2024
Table 44: North American Market for Glucose Monitoring and Diagnostic Products, by Country, Through 2024
Table 45: European Market for Glucose Monitoring and Diagnostics Products, by Country, Through 2024
Table 46: Asia-Pacific Market for Glucose Monitoring and Diagnostic Products, by Country, Through 2024
Table 47: Latin American Market for Glucose Monitoring and Diagnostic Products, by Country, Through 2024
Table 48: Middle Eastern and African Market for Glucose Monitoring and Diagnostic Products, by Country/Region, Through 2024
Table 49: Global Company Market Shares of Glucose Monitoring and Diagnostic Products, 2019
Table 50: Global Market Shares of Blood Glucose Test Strips, Glucose Meters, Lancets and Lancet Devices, by Company, 2019
Table 51: Global Company Market Shares of Continuous Glucose Monitoring Products, 2019
Table 52: Global Market for Insulin Delivery Products and Devices, Through 2024
Table 53: Global Market for Insulin Delivery Products and Devices, by Type, Through 2024
Table 54: Global Market Shares of Insulin Delivery Products and Devices, by Type, 2019
Table 55: Global Market Shares of Insulin Delivery Products and Devices, by Region, 2019
Table 56: Global Market for Insulin Delivery Products and Devices, by Region, Through 2024
Table 57: North American Market for Insulin Delivery Products and Devices, by Country, Through 2024
Table 58: European Market for Insulin Delivery Products and Devices, by Country, Through 2024
Table 59: Asia-Pacific Market for Insulin Delivery Products and Devices, by Country, Through 2024
Table 60: Latin American Market for Insulin Delivery Products and Devices, by Country, Through 2024
Table 61: Middle Eastern and African Market for Insulin Delivery Products and Devices, by Country/Region, Through 2024
Table 62: Global Company Market Shares of Insulin Delivery Products and Devices, 2019
Table 63: Global Market for Diabetic Pharmaceuticals, Through 2024
Table 64: Global Market for Diabetic Pharmaceuticals, by Product Type, Through 2024
Table 65: Global Market Shares of Diabetic Pharmaceuticals, by Product Type, 2019
Table 66: Global Revenues of Leading Antidiabetic Pharmaceutical Companies, 2016-2018
Table 67: Global Market Shares of Diabetic Pharmaceuticals, by Region, 2019
Table 68: Global Market for Diabetic Pharmaceuticals, by Region, Through 2024
Table 69: North American Market for Antidiabetic Pharmaceuticals, by Country, Through 2024
Table 70: European Market for Antidiabetic Pharmaceuticals, by Country, Through 2024
Table 71: Major Chinese Pharmaceutical Companies Developing Antidiabetic Medicines, by Type
Table 72: Asia-Pacific Market for Antidiabetic Pharmaceuticals, by Country, Through 2024
Table 73: Latin American Market for Antidiabetic Pharmaceuticals, by Country, Through 2024
Table 74: Middle Eastern and African Market for Antidiabetic Pharmaceuticals, by Country/Region, Through 2024
Table 75: Global Market Shares of Antidiabetic Pharmaceutical Companies, 2019
Table 76: Abbott Laboratories Revenue, by Business Segment, 2016-2018
Table 77: AstraZeneca PLC Revenue, by Business Segment, 2016-2018
Table 78: AstraZeneca PLC Revenue, by Individual Product, 2018
Table 79: Becton Dickinson Revenue, by Business Segment, 2016-2018
Table 80: Danaher Corp. Revenue, by Business Segment, 2016-2018
Table 81: Boston Scientific Corp. Revenue, by Product Segment, 2016-2018
Table 82: Boston Scientific Corp. Recent Developments, August 2018-May 2019
Table 83: B. Braun Melsungen AG Revenue, by Product Segment, 2016-2018
Table 84: Eli Lilly and Co. Revenue, by Product Segment, 2016-2018
Table 85: GlaxoSmithKline PLC Revenue, by Product Segment, 2016-2018
Table 86: Insulet Corp. Revenue, by Product Segment, 2016-2018
Table 87: Johnson & Johnson Revenue, by Product Segment, 2016-2018
Table 88: Medtronic Inc. Revenue, by Product Segment, 2017-2019
Table 89: Medtronic Inc. Recent Developments, June 2014-May 2019
Table 90: Novo Nordisk A/S Revenue, by Product Segment, 2016-2018
Table 91: Novo Nordisk A/S Revenue, Diabetes and Obesity, 2016-2018
Table 92: Novo Nordisk A/S Revenue, Biopharmaceuticals, 2016-2018
Table 93: Novo Nordisk A/S: Product Development Portfolio
Table 94: Pfizer Inc. Revenue, by Product Segment, 2016-2018
Table 95: Roche Group Revenue, by Product Segment, 2016-2018
Table 96: Roche Group Revenue, by Diagnostic Segment, 2016-2018
Table 97: Roche Group: Product Development Portfolio (Diagnostics)
Table 98: Sanofi S.A. Revenue, by Product Segment, 2016-2018
Table 99: Sanofi S.A. Diabetes Revenue, by Product Segment, 2016-2018
Table 100: Terumo Corp. Revenue, by Business Division, 2016-March 31, 2018
Table 101: Contact Information for Tier 1 Major Multinational Medical Device Corporations
Table 102: Contact Information for Tier 2 Entrepreneurial Small and Medium-Sized Enterprises
Table 103: Government Regulatory Agencies and Professional Organizations
Table 104: Acronyms and Terms Commonly Used in the Diagnosis, Monitoring and Treatment of Diabetes
LIST OF FIGURES
Summary Figure A: Global Market Sharehlcs of Diabetes Treatment, by Region, 2019
Summary Figure B: Global Market Shares of Diabetes Treatment, by Product Segment/Subsegment, 2019
Figure 1: Global Number of People Aged 20-79 Years Living with Diabetes, by Region, 2017 and 2045
Figure 2: Expenditure Gap in Diabetes: Total Amount Spent and Amount per Person Spent Across IDF Regions
Figure 3: The Hidden Diabetes Epidemic: Proportion of Early Deaths, Undiagnosed Diabetes and Number of People Living with Diabetes per Region
Figure 4: Administration Route for Insulin Delivery
Figure 5: Schematic of a Closed-loop Artificial Pancreas System
Figure 6: Schematic of the Edmonton Protocol
Figure 7: Product Pipeline Portfolio of Diabetology Ltd.
Figure 8: Classification of Injectable Therapies for Diabetes
Figure 9: Classification of Oral Antidiabetic Drugs (OADs)
Figure 10: Global Initiatives Pertaining to Type 2 Diabetes
Figure 11: Type 2 Diabetes Agents in Clinical Development
Figure 12: Clinical Development Pipeline for Hanmi Pharma Co. Ltd.
Figure 13: Global Market Shares of Diabetes Treatment Technologies, by Product Segment/Subsegment, 2019
Figure 14: Global Market Shares of Diabetes Treatment Technologies, by Product Segment/Subsegment, 2019
Figure 15: Global Market Shares of Diabetes Treatment Technologies, by Region, 2019
Figure 16: North American Market for Diabetes Treatment, by Product Segment, 2018-2024
Figure 17: European Market for Diabetes Treatment, by Product Segment, 2018-2024
Figure 18: Asia-Pacific Market for Diabetes Treatment, by Product Segment, 2018-2024
Figure 19: Latin American Market for Diabetes Treatment, by Product Segment, 2018-2024
Figure 20: Middle Eastern and African Market for Diabetes Treatments, by Product Segment, 2018-2024
Figure 21: Global Market Shares of Glucose Monitoring and Diagnostic Products, by Product Subsegment, 2019
Figure 22: Global Market Shares of Glucose Monitoring and Diagnostic Products, by Region, 2019
Figure 23: North American Market Shares of Glucose Monitoring and Diagnostic Products, by Country, 2019
Figure 24: European Market Shares of Glucose Monitoring and Diagnostic Products, by Country, 2019
Figure 25: Key Components of the German Statutory Health Insurance System, 2017
Figure 26: Evolution of Statutory Health Insurance Suppliers in Europe, 1970-2018
Figure 27: Asia-Pacific Market Shares of Glucose Monitoring and Diagnostic Products, by Country, 2019
Figure 28: Latin American Market Shares of Glucose Monitoring and Diagnostics Products, by Country, 2019
Figure 29: Middle Eastern and African Market Shares of Glucose Monitoring and Diagnostic Products, by Country/Region, 2019
Figure 30: Global Company Market Shares of Glucose Monitoring and Diagnostic Products, 2019
Figure 31: Global Company Market Shares of Blood Glucose Test Strips, Glucose Meters, Lancets and Lancet Devices, by Company,2019
Figure 32: Global Company Market Shares of Continuous Glucose Monitoring Products, 2019
Figure 33: Global Market Shares of Insulin Delivery Products and Devices, by Type, 2019
Figure 34: Global Market Shares of Insulin Delivery Products and Devices, by Region, 2019
Figure 35: North American Market Shares of Insulin Delivery Products and Devices, by Country, 2019
Figure 36: European Market Shares of Insulin Delivery Products and Devices, by Country, 2019
Figure 37: Asia-Pacific Market Shares of Insulin Delivery Products and Devices, by Country, 2019
Figure 38: Latin American Market Shares of Insulin Delivery Products and Devices, by Country, 2019
Figure 39: Middle East and African Market Shares of Insulin Delivery Products and Devices, by Country/Region, 2019
Figure 40: Global Company Market Shares of Insulin Delivery Products and Devices, 2019
Figure 41: Global Market Shares of Diabetic Pharmaceuticals, by Product Type, 2019
Figure 42: Evolution of the Top Selling Diabetes Drugs Globally, 2010-2018
Figure 43: Global Market Shares of Diabetic Pharmaceuticals, by Region, 2019
Figure 44: North American Market for Antidiabetic Pharmaceuticals, by Country, 2019
Figure 45: European Market Shares of Antidiabetic Pharmaceuticals, by Country, 2019
Figure 46: Asia-Pacific Market Shares of Antidiabetic Pharmaceuticals, by Country, 2019
Figure 47: Latin American Market Shares of Antidiabetic Pharmaceuticals, by Country, 2019
Figure 48: Middle Eastern and African Market Shares of Antidiabetic Pharmaceuticals, by Country/Region, 2019
Figure 49: Global Market Shares of Antidiabetic Pharmaceutical Companies, 2019
Summary Figure A: Global Market Sharehlcs of Diabetes Treatment, by Region, 2019
Summary Figure B: Global Market Shares of Diabetes Treatment, by Product Segment/Subsegment, 2019
Figure 1: Global Number of People Aged 20-79 Years Living with Diabetes, by Region, 2017 and 2045
Figure 2: Expenditure Gap in Diabetes: Total Amount Spent and Amount per Person Spent Across IDF Regions
Figure 3: The Hidden Diabetes Epidemic: Proportion of Early Deaths, Undiagnosed Diabetes and Number of People Living with Diabetes per Region
Figure 4: Administration Route for Insulin Delivery
Figure 5: Schematic of a Closed-loop Artificial Pancreas System
Figure 6: Schematic of the Edmonton Protocol
Figure 7: Product Pipeline Portfolio of Diabetology Ltd.
Figure 8: Classification of Injectable Therapies for Diabetes
Figure 9: Classification of Oral Antidiabetic Drugs (OADs)
Figure 10: Global Initiatives Pertaining to Type 2 Diabetes
Figure 11: Type 2 Diabetes Agents in Clinical Development
Figure 12: Clinical Development Pipeline for Hanmi Pharma Co. Ltd.
Figure 13: Global Market Shares of Diabetes Treatment Technologies, by Product Segment/Subsegment, 2019
Figure 14: Global Market Shares of Diabetes Treatment Technologies, by Product Segment/Subsegment, 2019
Figure 15: Global Market Shares of Diabetes Treatment Technologies, by Region, 2019
Figure 16: North American Market for Diabetes Treatment, by Product Segment, 2018-2024
Figure 17: European Market for Diabetes Treatment, by Product Segment, 2018-2024
Figure 18: Asia-Pacific Market for Diabetes Treatment, by Product Segment, 2018-2024
Figure 19: Latin American Market for Diabetes Treatment, by Product Segment, 2018-2024
Figure 20: Middle Eastern and African Market for Diabetes Treatments, by Product Segment, 2018-2024
Figure 21: Global Market Shares of Glucose Monitoring and Diagnostic Products, by Product Subsegment, 2019
Figure 22: Global Market Shares of Glucose Monitoring and Diagnostic Products, by Region, 2019
Figure 23: North American Market Shares of Glucose Monitoring and Diagnostic Products, by Country, 2019
Figure 24: European Market Shares of Glucose Monitoring and Diagnostic Products, by Country, 2019
Figure 25: Key Components of the German Statutory Health Insurance System, 2017
Figure 26: Evolution of Statutory Health Insurance Suppliers in Europe, 1970-2018
Figure 27: Asia-Pacific Market Shares of Glucose Monitoring and Diagnostic Products, by Country, 2019
Figure 28: Latin American Market Shares of Glucose Monitoring and Diagnostics Products, by Country, 2019
Figure 29: Middle Eastern and African Market Shares of Glucose Monitoring and Diagnostic Products, by Country/Region, 2019
Figure 30: Global Company Market Shares of Glucose Monitoring and Diagnostic Products, 2019
Figure 31: Global Company Market Shares of Blood Glucose Test Strips, Glucose Meters, Lancets and Lancet Devices, by Company,2019
Figure 32: Global Company Market Shares of Continuous Glucose Monitoring Products, 2019
Figure 33: Global Market Shares of Insulin Delivery Products and Devices, by Type, 2019
Figure 34: Global Market Shares of Insulin Delivery Products and Devices, by Region, 2019
Figure 35: North American Market Shares of Insulin Delivery Products and Devices, by Country, 2019
Figure 36: European Market Shares of Insulin Delivery Products and Devices, by Country, 2019
Figure 37: Asia-Pacific Market Shares of Insulin Delivery Products and Devices, by Country, 2019
Figure 38: Latin American Market Shares of Insulin Delivery Products and Devices, by Country, 2019
Figure 39: Middle East and African Market Shares of Insulin Delivery Products and Devices, by Country/Region, 2019
Figure 40: Global Company Market Shares of Insulin Delivery Products and Devices, 2019
Figure 41: Global Market Shares of Diabetic Pharmaceuticals, by Product Type, 2019
Figure 42: Evolution of the Top Selling Diabetes Drugs Globally, 2010-2018
Figure 43: Global Market Shares of Diabetic Pharmaceuticals, by Region, 2019
Figure 44: North American Market for Antidiabetic Pharmaceuticals, by Country, 2019
Figure 45: European Market Shares of Antidiabetic Pharmaceuticals, by Country, 2019
Figure 46: Asia-Pacific Market Shares of Antidiabetic Pharmaceuticals, by Country, 2019
Figure 47: Latin American Market Shares of Antidiabetic Pharmaceuticals, by Country, 2019
Figure 48: Middle Eastern and African Market Shares of Antidiabetic Pharmaceuticals, by Country/Region, 2019
Figure 49: Global Market Shares of Antidiabetic Pharmaceutical Companies, 2019
